M. Jinek et al. “A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity,” Science 337, 816 (2012).
J. Hemphill et al. “Optical control of CRISPR/Cas9 gene editing,” J. Am. Chem. Soc. 137, 5642 (2015).
Y. Nihongaki et al. “Photoactivatable CRISPR-Cas9 for optogenetic genome editing,” Nat. Biotechnol. 33, 755 (2015).
F. Bubeck et al. “Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9,” Nat. Meth. 15, 924 (2018).
X.X. Zhou et al. “A single-chain photoswitchable CRISPR-Cas9 architecture for light-inducible gene editing and transcription,” ACS Chem. Biol. 13, 443 (2018).
Y. Pan et al. “Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform,” Sci. Adv. 5, eaav7199 (2019).
X. Chen et al. “Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing,” Proc. Natl. Acad. Sci. USA 117, 2395 (2020).
Y. Chen et al. “Optical manipulation of CRISPR/Cas9 functions: From ultraviolet to near-infrared light,” ACS Mater. Lett. 2, 644 (2020).
M.D. Hoffmann et al. “Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein,” Nucl. Acids Res. 49, e29 (2020).
C. Arnold. “What’s new in clinical CRISPR?,” Nat. Medicine 27, 184 (2021).